Scilex Holding Company Common Stock

Scilex Holding Company announced a binding term sheet with Kazakhstan-based iHolding Group LLP for a $100 million strategic investment at $15 per share (approximately 6.67 million shares). The investment will support Scilex's growth initiatives including product development, commercialization, acquisitions, and strategic partnerships. The deal re...

Scilex Holding Company shares surged 18.79% after announcing that its Dream Bowl I Meme Coin tokens will begin trading on Biconomy Exchange as early as June 23. The listing is expected to improve liquidity and enable broader distribution for eligible token holders. Scilex is a biotech company focused on non-opioid pain management products.

Scilex Holding Company announced that its board has set June 15, 2026 as the payment date for a dividend of Semnur Pharmaceuticals common stock to Scilex shareholders. The company plans to distribute approximately 14.0 million shares of Semnur (out of 186 million owned) on a 1:1 basis for each Scilex share held as of the June 1, 2026 record date....

Scilex Holding Company's board approved a dividend distribution of Semnur Pharmaceuticals common stock to its shareholders, with a record date of June 1, 2026. Scilex will distribute approximately 10.7 million shares of its ~186 million Semnur holdings to eligible equity holders at a 1:1 ratio. The payment date will be determined by subsequent bo...

Scilex Holding Company announced that its subsidiaries ACEA Therapeutics and ACEA Pharma entered into a definitive agreement to sell 100% of ACEA Pharma's equity to Phoenix Asia Holdings Limited for $1 billion in newly-issued shares. Upon closing, Phoenix will be renamed ACEA Pharma and listed on Nasdaq, with ACEA Thera retaining approximately 82...